Recent Progress in Biosensors for Detection of Tumor Biomarkers

Abstract

Cancer is a leading cause of death worldwide, with an increasing mortality rate over the past years. The early detection of cancer contributes to early diagnosis and subsequent treatment. How to detect early cancer has become one of the hot research directions of cancer. Tumor biomarkers, biochemical parameters for reflecting cancer occurrence and progression have caused much attention in cancer early detection. Due to high sensitivity, convenience and low cost, biosensors have been largely developed to detect tumor biomarkers. This review describes the application of various biosensors in detecting tumor markers. Firstly, several typical tumor makers, such as neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), prostate-specific antigen (PSA), squamous cell carcinoma antigen (SCCA), carbohydrate, antigen19-9 (CA19-9) and tumor suppressor p53 (TP53), which may be helpful for early cancer detection in the clinic, are briefly described. Then, various biosensors, mainly focusing on electrochemical biosensors, optical biosensors, photoelectrochemical biosensors, piezoelectric biosensors and aptamer sensors, are discussed. Specifically, the operation principles of biosensors, nanomaterials used in biosensors and the application of biosensors in tumor marker detection have been comprehensively reviewed and provided. Lastly, the challenges and prospects for developing effective biosensors for early cancer diagnosis are discussed.

Electrospun nanofibers synthesis enhancing the activity of energy storage devices/electrochemical and biosensor applications

“…Filtration is the act of removing suspended particles from a fluid using porous medium due to growing concerns about human health and environmental issues such as air and water pollution. The dispersion medium can be liquid, air, or a gas/gas combination [198]. Porous media, like membranes, are employed in filtration to remove dispersed particles from any solution using a variety of techniques, including electrospinning [199].…”

Tumor biomarkers for diagnosis, prognosis and targeted therapy

“… 166 The serum level of SCCA correlates with the stage, the degree of invasion, recurrence, and the progression of cervical SCC. 159 Cervical cancer patients with a high-level of pretreatment serum SCCA exhibit a higher risk for death than patients with low serum SCCA. Pretreatment SCCA cutoff ranging from 1.1 to 40.0 ng/mL is related to recurrence and death.…”

Can Nano Yield Big Insights? Oligonucleotide-Based Biosensors in Early Diagnosis of Gastric Cancer

“…Traditional and current diagnostic practices are upper gastrointestinal (UGI) endoscopy followed by biopsy sampling and histopathological examination [2,11], with 9.4% of cancers missed, as demonstrated by a meta-analysis by Pimenta-Melo et al (2016) involving over 69,000 patients [12,13]. Some of the reasons are a detectable tumor size requirement of ≥5 mm [14], younger age, gender and the gastric pathologies trio, atrophy, adenoma or ulcer [12,13].…”